<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://allsci.com/news/business/celularity-funding-recapitalization-closes-usd/</loc>
    <news:news>
      <news:publication><news:name>AllSci</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-09-28T09:25:47.187780Z</news:publication_date>
      <news:title>Celularity raises USD 10m in first tranche of USD 28m recapitalization</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://allsci.com/news/business/ligand-avencell-car-t-funding-commits-usd-41m/</loc>
    <news:news>
      <news:publication><news:name>AllSci</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-09-28T09:02:00.588743Z</news:publication_date>
      <news:title>Ligand backs AvenCell CAR-T pipeline with up to USD 47m</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://allsci.com/news/business/scancell-blackrock-melanoma-trial-funding/</loc>
    <news:news>
      <news:publication><news:name>AllSci</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-09-28T08:31:09.361907Z</news:publication_date>
      <news:title>Scancell secures USD 25m debt facility from BlackRock to fund iSCIB1+ Phase III melanoma trial</news:title>
    </news:news>
  </url>
</urlset>